ArticleJournal of clinical medicine2025

Safety and Effectiveness of Multi-Switch Between Adalimumab Originator and Biosimilars: A Multicenter (SUSTAIN) Study.

Mohammad Shehab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.